A recent trial comparing two weight-loss medications, Mounjaro and Wegovy, revealed that Mounjaro is significantly more effective, achieving a 20% weight reduction over 72 weeks versus 14% with Wegovy. While both drugs help reduce appetite and promote fat burning, Mounjaro's mechanism, which influences two hormones as opposed to one in Wegovy, accounts for its superior results. Additionally, Mounjaro users experienced improved health markers like blood pressure and cholesterol levels, suggesting it may be a preferred option for individuals with higher obesity levels.
The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy, yielding superior weight reduction results.
Researchers found that Mounjaro leads to a 20% weight reduction over 72 weeks, compared to 14% with Wegovy, indicating its potential for more significant weight loss.
Mounjaro flips two appetite-controlling hormones, allowing greater effectiveness for those struggling with obesity compared to Wegovy's single hormone approach.
With 32% of Mounjaro participants losing a quarter of their body weight, it may offer more substantial improvements for individuals with higher obesity levels.
Collection
[
|
...
]